WallStSmart

Medtronic PLC (MDT)vsSemler Scientific Inc (SMLR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 82463% more annual revenue ($35.48B vs $42.98M). SMLR leads profitability with a 86.2% profit margin vs 13.0%. SMLR trades at a lower P/E of 5.0x. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

SMLR

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 6.0Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued
SMLRUndervalued (+90.5%)

Margin of Safety

+90.5%

Fair Value

$213.41

Current Price

$20.33

$193.08 discount

UndervaluedFair: $213.41Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

SMLR4 strengths · Avg: 10.0/10
P/E RatioValuation
5.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Profit MarginProfitability
86.2%10/10

Keeps 86 of every $100 in revenue as profit

EPS GrowthGrowth
3570.1%10/10

Earnings expanding 3570.1% YoY

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

SMLR4 concerns · Avg: 2.0/10
Market CapQuality
$348.27M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-43.2%2/10

Revenue declined 43.2%

Free Cash FlowQuality
$-32.96M2/10

Negative free cash flow — burning cash

Operating MarginProfitability
-25.0%1/10

Operating margin of -25.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : SMLR

The strongest argument for SMLR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 86.2% and operating margin at -25.0%.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : SMLR

The primary concerns for SMLR are Market Cap, Revenue Growth, Free Cash Flow.

Key Dynamics to Monitor

MDT profiles as a value stock while SMLR is a declining play — different risk/reward profiles.

SMLR carries more volatility with a beta of 1.33 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 53/100). SMLR offers better value entry with a 90.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Semler Scientific Inc

HEALTHCARE · MEDICAL DEVICES · USA

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that help healthcare providers evaluate and treat patients with chronic conditions in the United States. The company is headquartered in Santa Clara, California.

Want to dig deeper into these stocks?